Fortrea Holdings Inc.

Last updated September 27, 2026

Organization details

Legal name
Fortrea Holdings Inc.
Former names
Silver Spinco Inc.
Ownership
Public
Status
Active
SIC code
8071 — Services-Medical Laboratories
Headquarters city
Durham
Headquarters state / province
North Carolina
Headquarters country
United States
Fiscal year end
December
Ticker symbol
FTRE
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001965040
EIN
92-2796441

Board of directors

Chief executives

Anshul Thakral · Chief Executive Officer
Since August 2025
Thomas Pike · Chief Executive Officer
Until August 2025 · Former
Peter M. Neupert · Chief Executive Officer
Until August 2025 · Former

Director election results

Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 14 other boards.

Network of Fortrea Holdings Inc.'s board connections Accendra Health Inc. Accendra Health Inc. Adaptive Biotechnologies Corporation Adaptive Biotechnologi... Becton Dickinson and Company Becton Dickinson and C... BioCryst Pharmaceuticals Inc. BioCryst Pharmaceutica... Kadant Inc Kadant Inc Labcorp Holdings Inc. Labcorp Holdings Inc. Lumexa Imaging Holdings Inc. Lumexa Imaging Holding... Maravai LifeSciences Holdings Inc. Maravai LifeSciences H... Martin Marietta Materials Inc. Martin Marietta Materi... MiniMed Group Inc. MiniMed Group Inc. Solventum Corporation Solventum Corporation The Middleby Corporation The Middleby Corporati... Ultragenyx Pharmaceutical Inc. Ultragenyx Pharmaceuti... eHealth Inc. eHealth Inc. Amrit Ray Amrit Ray Edward A. Pesicka Edward A. Pesicka Erin L. Russell Erin L. Russell Glenn A. Eisenberg Glenn A. Eisenberg Machelle Sanders Machelle Sanders Peter M. Neupert Peter M. Neupert R. Andrew Eckert R. Andrew Eckert Thomas Pike Thomas Pike Fortrea Holdings Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$4,683,483
24 sales by 6 insiders
Date Insider Transaction Shares Price Value
Sep 9, 2026 Morais Mark A. Officer (Chief Operating Officer) Open-market sale −3,149 $16.85 $53,061
Sep 9, 2026 Russell Carrie Elizabeth Officer (Interim CAO) Open-market sale −246 $16.85 $4,145
Sep 8, 2026 Morais Mark A. Officer (Chief Operating Officer) Option exercise +7,157 — —
Sep 8, 2026 Russell Carrie Elizabeth Officer (Interim CAO) Option exercise +850 — —
Aug 19, 2026 Morais Mark A. Officer (Chief Operating Officer) Open-market sale −4,892 $18.19 $88,985
Aug 18, 2026 Morais Mark A. Officer (Chief Operating Officer) Option exercise +11,313 — —
Aug 6, 2026 Anshul Thakral Director, Officer (Chief Executive Officer) Open-market sale −55,882 $18.17 $1,015,376
Aug 6, 2026 Anshul Thakral Director, Officer (Chief Executive Officer) Open-market sale −55,975 $18.06 $1,010,909
Aug 5, 2026 Anshul Thakral Director, Officer (Chief Executive Officer) Open-market sale −49,452 $19.03 $941,072
Aug 5, 2026 Anshul Thakral Director, Officer (Chief Executive Officer) Open-market sale −50,417 $19.28 $972,040
Aug 4, 2026 Anshul Thakral Director, Officer (Chief Executive Officer) Option exercise +416,666 — —
Aug 3, 2026 Machelle Sanders Director Open-market sale −9,700 $18.01 $174,697
Jul 20, 2026 David Ross Smith Director Option exercise +6,598 — —
Jun 10, 2026 Machelle Sanders Director Option exercise +38,817 — —
Jun 10, 2026 David Ross Smith Director Option exercise +38,817 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.